Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review

Affiliations

¹ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
³ Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁴ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Section of Dermatology, Division of Pediatric Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: cathryn.sibbald@sickkids.ca.

Muskaan Sachdeva et al. J Am Acad Dermatol. 2021 Oct.

. 2021 Oct;85(4):1011-1013.

doi: 10.1016/j.jaad.2020.12.080. Epub 2021 Jan 8.

¹ Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
³ Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
⁴ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Section of Dermatology, Division of Pediatric Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: cathryn.sibbald@sickkids.ca.

No abstract available

Conflict of interest statement

Conflicts of interest None disclosed.

Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.
Ramien ML, Mansour D, Shear NH. Ramien ML, et al. Paediatr Drugs. 2022 Jul;24(4):307-319. doi: 10.1007/s40272-022-00515-0. Epub 2022 Jun 9. Paediatr Drugs. 2022. PMID: 35676614 Review.
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A, Olabi B, Langley A, Beecker J, Mutter E, Shelley A, Worley B, Ramsay T, Saavedra A, Parker R, Stewart F, Pardo Pardo J. Jacobsen A, et al. Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article.
Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.
Tonkin R, Ladha M, Johnson N, Astle WF, Britton A, Shear NH, Murguía-Favela L, Ramien M. Tonkin R, et al. SAGE Open Med Case Rep. 2022 Aug 17;10:2050313X221117887. doi: 10.1177/2050313X221117887. eCollection 2022. SAGE Open Med Case Rep. 2022. PMID: 36003890 Free PMC article.